Journal of Cutaneous Immunology and Allergy

Original Research

Published on 09 Dec 2025

Modulation of keratinocyte proliferation, migration, and differentiation by calcium and magnesium

Kazushi Hirakata
Miyabi Hiyama
Hideyuki Itabashi
Akihiko Uchiyama
Sei-Ichiro Motegi

Journal of Cutaneous Immunology and Allergy

doi 10.3389/jcia.2025.15491

Case Report

Published on 01 Dec 2025

Case Report: Dermatomyositis with symmetrical axillary and inguinal panniculitis associated with anti-NXP-2

Eri Uchiyama
Mei Tochigi
Yuko Takamiya
Akira Shimizu
Takashi Matsushita
Kazunori Yamada

Journal of Cutaneous Immunology and Allergy

doi 10.3389/jcia.2025.15763

Brief Research Report

Published on 27 Nov 2025

Diagnostics of cutaneous adverse drug reactions: evaluation of patch tests, lymphocyte transformation tests, and drug provocation tests

Tomomu Ishikawa
Risa Tamagawa-Mineoka
Koji Masuda
Norito Katoh
Takeshi Fukumoto

Journal of Cutaneous Immunology and Allergy

doi 10.3389/jcia.2025.15760

Letter to the Editor

Published on 20 Nov 2025

Temporal dynamics of cytokine production balance between innate and adaptive lymphocytes in atopic dermatitis model mice

Mai Nishimura
Yoshiaki Matsushima
Yasutomo Imai
Keiichi Yamanaka

Journal of Cutaneous Immunology and Allergy

doi 10.3389/jcia.2025.15510

Letter to the Editor

Published on 17 Nov 2025

Changes in biologic treatment patterns for psoriasis before and after the COVID-19 pandemic in Japan; a single center retrospective study

Natsumi Ikumi
Hideki Fujita

Journal of Cutaneous Immunology and Allergy

doi 10.3389/jcia.2025.15613

Case Report

Published on 08 Oct 2025

Case Report: Blister formation with transient drug hypersensitivity following CAR-T-cell therapy

Natsu Watanabe
Nobuo Kanazawa
Satoshi Yoshihara

Journal of Cutaneous Immunology and Allergy

doi 10.3389/jcia.2025.15280

Original Research

Published on 22 Sep 2025

The possible effectiveness of difamilast in improving barrier dysfunction in patients with atopic dermatitis and in mouse model

Akihiko Uchiyama
Bayarmaa Taivanbat
Keiji Kosaka
Mai Ishikawa
Akihito Uehara
Masatoshi Shimaoka
Keiichiro Ryuzaki
Sei-Ichiro Motegi

Journal of Cutaneous Immunology and Allergy

doi 10.3389/jcia.2025.15151

Case Report

Published on 11 Sep 2025

Case Report: First reports of Schnitzler syndrome in Iran: clinical presentation and therapeutic challenges

Mohammad Aminianfar
Saeed Soleiman-Meigooni
Shadi Mohammadi
Mahdieh Aminianfar

Journal of Cutaneous Immunology and Allergy

doi 10.3389/jcia.2025.15322

Letter to the Editor

Published on 14 Aug 2025

Two cases of severe childhood-onset psoriasis successfully treated with risankizumab in patients with Down syndrome and morbid obesity

Yoshiaki Hara
Tomomitsu Miyagaki
Tatsuro Okano
Takafumi Kadono
Hidenori Watabe

Journal of Cutaneous Immunology and Allergy

doi 10.3389/jcia.2025.15043

Letter to the Editor

Published on 11 Aug 2025

Association between the neutrophil percentage-to-albumin ratio and generalized pustular psoriasis

Arisa Yoshimura
Shinichi Sato
Sayaka Shibata

Journal of Cutaneous Immunology and Allergy

doi 10.3389/jcia.2025.15227

Letter to the Editor

Published on 22 Jul 2025

Severe lichenified skin rash associated with apalutamide administration

Chisato Watanabe
Shujiro Hayashi
Shown Tokoro
Ken Igawa

Journal of Cutaneous Immunology and Allergy

doi 10.3389/jcia.2025.14936

Letter to the Editor

Published on 14 Jul 2025

Successful conservative management of massive oxaliplatin extravasation from a central venous port with early systemic corticosteroid therapy

Shunsuke Takahagi
Mayu Kanamoto
Hikari Sakamoto

Journal of Cutaneous Immunology and Allergy

doi 10.3389/jcia.2025.15049

Letter to the Editor

Published on 10 Jul 2025

Two cases of Stevens-Johnson syndrome presenting severe ocular complications associated with immune checkpoint inhibitor

Yukiko Nakahara-Omori
Yukari Kobayashi
Sumiko Ishizaki
Kyoko Chujo
Chikako Suto
Masaru Tanaka
Noriko Umegaki-Arao

Journal of Cutaneous Immunology and Allergy

doi 10.3389/jcia.2025.14843

Original Research

Published on 09 Jul 2025

Real-world safety and effectiveness of dupilumab for the treatment of atopic dermatitis: two-year post-marketing surveillance in Japan

Hidehisa Saeki
Makiko Usami
Katsuhisa Suzuki
Michika Mochizuki
Kazuhiko Arima

Journal of Cutaneous Immunology and Allergy

doi 10.3389/jcia.2025.14794

Original Research

Published on 10 Jun 2025

An open-label interventional clinical study evaluating sweating function in dupilumab treatment for atopic dermatitis

Mai Matsumoto
Yuta Koike
Motoi Takenaka
Hiroyuki Murota

Journal of Cutaneous Immunology and Allergy

doi 10.3389/jcia.2025.14517

Letter to the Editor

Published on 09 Jun 2025

Contact urticaria from medical gowns and gloves in a midwife student

Eri Hashimoto
Takehiro Okusa
Tatsunori Hamamoto
Yuta Ito
Yoshiaki Ikarashi
Tokio Nakada

Journal of Cutaneous Immunology and Allergy

doi 10.3389/jcia.2025.14731

Letter to the Editor

Published on 04 Jun 2025

Successful treatment by deucravacitinib of psoriasis refractory to apremilast

Shigeki Inui
Yukinobu Nakagawa
Manabu Fujimoto

Journal of Cutaneous Immunology and Allergy

doi 10.3389/jcia.2025.14639

Letter to the Editor

Published on 30 May 2025

Fatal toxic epidermal necrolysis associated with an immune checkpoint inhibitor

Chiaki Seki
Yuta Koike
Misato Higuchi
Eri Ikenaga
Tomoka Waseda
Mio Ichiki
Daisuke Ehara
Motoi Takenaka
Keiko Kusano
Yuuki Sonoda

Journal of Cutaneous Immunology and Allergy

doi 10.3389/jcia.2025.14584

Letter to the Editor

Published on 28 Apr 2025

Successful treatment of familial cases of epidermolysis bullosa pruriginosa with dupilumab

Maya Kaga
Yasushi Suga
Akira Ishiko

Journal of Cutaneous Immunology and Allergy

doi 10.3389/jcia.2025.14677

Case Report

Published on 28 Apr 2025

Case Report: The relation between the incidence of disseminated intravascular coagulation in scrub typhus cases and its serotype in northeastern Japan

Haruka Sato
Naoko Enzan
Yukiko Akasaka
Harumi Yajima
Michihiro Kono

Journal of Cutaneous Immunology and Allergy

doi 10.3389/jcia.2025.14673

Letter to the Editor

Published on 08 Apr 2025

Diffuse large B-cell lymphoma misdiagnosed as cellulitis

Tamotsu Kuribayashi
Mayumi Komine
Mayumi Baba
Nobuhito Ohnou
Yoshinori Morita

Journal of Cutaneous Immunology and Allergy

doi 10.3389/jcia.2025.14541

Original Research

Published on 01 Apr 2025

Establishment of α-Gal-specific IgE cutoff value to prevent cetuximab-induced allergic reactions in potential α-Gal syndrome

Linjie Tian
Yuko Chinuki
Kunie Kohno
Yusei Nakagawa
Takeyasu Kakamu
Kazuyuki Ito
Kenichiro Nakajima
Sato Ichihashi
Osamu Yamasaki
Xiaolin Bu

Journal of Cutaneous Immunology and Allergy

doi 10.3389/jcia.2025.14348

Brief Research Report

Published on 26 Mar 2025

An allergic subtype of acquired idiopathic generalized anhidrosis resistant to steroid pulse therapy – a retrospective, single-center, cohort study

Maiko Fujita
Tadatsune Iida
Chie Uchida
Minako Inazawa
Hana Takeshita
Tomoko Fujimoto
Takeshi Namiki
Hiroo Yokozeki
Naoko Okiyama

Journal of Cutaneous Immunology and Allergy

doi 10.3389/jcia.2025.14190

Letter to the Editor

Published on 13 Mar 2025

Generalized pustular psoriasis with breast cancer successfully treated with granulocyte and monocyte adsorptive aphaeresis and brodalumab

Miho Takahashi
Hitoshi Tsuchihashi
Rei Watanabe

Journal of Cutaneous Immunology and Allergy

doi 10.3389/jcia.2025.14441

407 Publications

volumes

Volume 8 - 2025

Modulation of keratinocyte proliferation, migration, and differentiation by calcium and magnesium

Case Report: Dermatomyositis with symmetrical axillary and inguinal panniculitis associated with anti-NXP-2

Diagnostics of cutaneous adverse drug reactions: evaluation of patch tests, lymphocyte transformation tests, and drug provocation tests

Temporal dynamics of cytokine production balance between innate and adaptive lymphocytes in atopic dermatitis model mice

Changes in biologic treatment patterns for psoriasis before and after the COVID-19 pandemic in Japan; a single center retrospective study

Case Report: Blister formation with transient drug hypersensitivity following CAR-T-cell therapy

The possible effectiveness of difamilast in improving barrier dysfunction in patients with atopic dermatitis and in mouse model

Case Report: First reports of Schnitzler syndrome in Iran: clinical presentation and therapeutic challenges

Two cases of severe childhood-onset psoriasis successfully treated with risankizumab in patients with Down syndrome and morbid obesity

Association between the neutrophil percentage-to-albumin ratio and generalized pustular psoriasis

Severe lichenified skin rash associated with apalutamide administration

Successful conservative management of massive oxaliplatin extravasation from a central venous port with early systemic corticosteroid therapy

Two cases of Stevens-Johnson syndrome presenting severe ocular complications associated with immune checkpoint inhibitor

Real-world safety and effectiveness of dupilumab for the treatment of atopic dermatitis: two-year post-marketing surveillance in Japan

An open-label interventional clinical study evaluating sweating function in dupilumab treatment for atopic dermatitis

Contact urticaria from medical gowns and gloves in a midwife student

Successful treatment by deucravacitinib of psoriasis refractory to apremilast

Fatal toxic epidermal necrolysis associated with an immune checkpoint inhibitor

Successful treatment of familial cases of epidermolysis bullosa pruriginosa with dupilumab

Case Report: The relation between the incidence of disseminated intravascular coagulation in scrub typhus cases and its serotype in northeastern Japan

Diffuse large B-cell lymphoma misdiagnosed as cellulitis

Establishment of α-Gal-specific IgE cutoff value to prevent cetuximab-induced allergic reactions in potential α-Gal syndrome

An allergic subtype of acquired idiopathic generalized anhidrosis resistant to steroid pulse therapy – a retrospective, single-center, cohort study

Generalized pustular psoriasis with breast cancer successfully treated with granulocyte and monocyte adsorptive aphaeresis and brodalumab